Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
REPROCELL develops and supplies human iPSC-derived cells, primary human biospecimens and related cell-based tools for research and drug discovery. The company offers preclinical assay services using fresh human tissues, molecular and assay development services, and contract research to support drug discovery and regenerative medicine programs. Founded in 2003 with operations and partnerships across the United States, United Kingdom, India and Japan, REPROCELL serves pharmaceutical, biotech and academic customers worldwide.